Market research
FIXX Homology Medicines Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 1.5
- Dividend yield
- Not available
- Beta
- -0.11
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- US4380831077
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 1.5
- Dividend yield
- Not available
- Beta
- -0.11
About
About Homology Medicines Inc
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the FIXX discussion.
5 years, 4 months ago
Homology Medicines, Inc is currently in a long term downtrend where the price is trading 32.3% below its 200 day moving average.
From a valuation standpoint, the stock is 87.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 163.8.
Homology Medicines, Inc's total revenue rose by 74.1% to $980K since the same quarter in the previous year.
Its net income has dropped by 23.3% to $-30M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.2% to $-13M since the same quarter in the previous year.
Based on the above factors, Homology Medicines, Inc gets an overall score of 3/5.